The diagnosis and medical management of advanced neuroendocrine tumors.
The DOI matches its Crossref record; 657 of the 670 references it cites were found in a registry or an index.
Abstract
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that originate from endocrine glands such as the pituitary, the parathyroids, and the (neuroendocrine) adrenal, as well as endocrine islets within glandular tissue (thyroid or pancreatic) and cells dispersed between exocrine cells, such as endocrine cells of the digestive (gastroenteropancreatic) and respiratory tracts. Conventionally, NETs may present with a wide variety of functional or nonfunctional endocrine syndromes and may be familial and have other associated tumors. Assessment of specific or general tumor markers offers high sensitivity in establishing the diagnosis and can also have prognostic significance. Imaging modalities include endoscopic ultrasonography, computed tomography and magnetic resonance imaging, and particularly, scintigraphy with somatostatin analogs and metaiodobenzylguanidine. Successful treatment of disseminated NETs requires a multimodal approach; radical tumor surgery may be curative but is rarely possible. Well-differentiated and slow-growing gastroenteropancreatic tumors should be treated with somatostatin analogs or alpha-interferon, with chemotherapy being reserved for poorly differentiated and progressive tumors. Therapy with radionuclides may be used for tumors exhibiting uptake to a diagnostic scan, either after surgery to eradicate microscopic residual disease or later if conventional treatment or biotherapy fails. Maintenance of the quality of life should be a priority, particularly because patients with disseminated disease may experience prolonged survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the combination of noninvasive and selected invasive modalities (particularly endoscopic ultrasound), most insulinomas are localized preoperatively (72, 78).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [72]
In the citing paper
“Although the results with a given method reflect the experience and expertise with that method at a given center, computed tomography, MRI, and transabdominal ultrasonography detect most insulinomas (71-73).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [72]
Citations
Cites
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
Gutmann, D. H. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550010065042 · Cited by 1,359
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
The Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity
CARNEY, J. A., GORDON, H., CARPENTER, P. C., SHENOY, B. V., & W. GO, V. L. (1985) · Medicine · doi:10.1097/00005792-198507000-00007 · Cited by 1,114
Research works printed but not linked: 3
- Krenning, 1994, Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide., Semin Oncol, 21, 6
- Janson, 2000, Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors., J Nucl Med, 41, 1514
- Bartsch, 1990, Treatment of metastatic carcinoid tumors by recombinant human interferon-α. Results from a phase II study., J Cancer Res Clin Oncol, 116, 305
Cited by
Items 401–500 of 679
An Overview of Neuroendocrine Tumour Markers
Özaslan, E., Diri, H., Karacan, H., Şimşek, Y., & Bayram, F. (2014) · Endocrinology research and practice. · doi:10.4274/tjem.2422 · Cited by 6
“The syndrome may also occur when the carcinoid tumor is located in the bronchi, ovary, kidney, testes or thymus, not within the gastrointestinal tract (6,19).”
BackgroundInfluential[Contemporary methods of diagnosis and treatment of neuroendocrine gastrointestinal tumors].
Kos‐Kudła, B., & Zemczak, A. (2006) · PubMed · Cited by 6
Das, S., Sakhare, N., Mathur, A., Mallia, M. B., Mirapurkar, S., Sheela, M. A. A., Sarma, H. D., Sachdev, S. S., & Dash, A. K. (2019) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2019.01.001 · Cited by 4
Feretis, M., Wang, T., Ghorani, E., Balakrishnan, A., Harper, S., Jah, A., Huguet, E., Praseedom, R., & Liau, S. (2019) · Pancreatology · doi:10.1016/j.pan.2019.08.005 · Cited by 4
Fust, K., Maschio, M., Kohli, M. A., Singh, S., Pritchard, D. M., Marteau, F., Myrenfors, P., & Feuilly, M. (2020) · PharmacoEconomics · doi:10.1007/s40273-020-00896-5 · Cited by 4
“CS develops most commonly in patients with small intestinal NETs and hepatic metastases [3, 6] and less commonly in patients with pancreatic tumours or lung NETs; CS can also occur when secretions drain directly from tumours into the central circulation [3, 7–9].”
BackgroundGenetics of Pituitary Adenomas
Bogusławska, A., Gilis‐Januszewska, A., & Korbonits, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-90475-3_4 · Cited by 6
Primary Retroperitoneal Inter-aorto-Caval paraganglioma of the Organ of Zuckerkandl
Vikas, V. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/6773.4619 · Cited by 4
Huang, Z., Liang, G., Shen, H. M., Hong, C., Yin, X., & Zhang, S. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.922112 · Cited by 4
“In contrast, those with non-functional retro-peritoneal paragangliomas are often diagnosed incidentally or manifest as compressive symptoms such as abdominal pain that may be associated with nausea, vomiting, abdominal distension, weight loss, or even paralytic ileus (8, 11, 12).”
BackgroundCannon, J., & Doherty, G. M. (2008) · Endocrine Practice · doi:10.4158/ep.14.5.588 · Cited by 4
Igarashi, H., Ito, T., Yoshinaga, M., Kodama, M., Hayashi, H., Sakai, H., Kawabe, K., & Takayanagi, R. (2007) · Pancreas · doi:10.1097/mpa.0b013e3180654d44 · Cited by 4
A Novel Von Hippel–Lindau Point Mutation Presents as Apparently Sporadic Pheochromocytoma
Rich, T. A., Jonasch, E. W., Matin, S. F., Waguespack, S. G., Gombos, D. S., Santarpia, L., Stolle, C. A., & Jiménez, C. (2008) · Cancer Investigation · doi:10.1080/07357900701802527 · Cited by 4
“Renal and pancreatic cysts as well as epididymal cysts in men and broad ligament cysts in women are also common manifestations of this condition (4).”
BackgroundKos‐Kudła, B., Bolanowski, M., Hubalewska–Dydejczyk, A., Krzakowski, M. J., Marek, B., Nasierowska-Guttmejer, A. M., Lampe, P., & Sworczak, K. (2008) · PubMed · Cited by 4
Rare presentation of occult medullary carcinoma of the thyroid as a mediastinal mass
Daraki, V. N., Koukouraki, S., Velegrakis, G. A., Mamalaki, E., Haniotis, V., Kalikakis, G., Stathaki, M. I., Karkavitsas, N. S., & Papavasiliou, S. S. (2012) · HORMONES · doi:10.14310/horm.2002.1350 · Cited by 4
An Ileal Endometrioma: Of Carcinoids and Cadherin
Pannala, R., Gafni‐Kane, A., Kidd, M. S., & Modlin, I. M. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-006-0080-0 · Cited by 4
Lung Fibrosis in Carcinoid Syndrome
Tamagno, G., Goglia, U., Villa, G., & Murialdo, G. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.6367 · Cited by 4
“Despite intensive treatment with octreotide, interferon-α, corticosteroids, ondansetron, and cyproheptadine (1), bronchostenosis and severe impairment of gas exchange with respiratory acidosis (pH 7.”
BackgroundNeuroendocrine Tumors — Laboratory Diagnosis
Tzontcheva, A. (2010) · Journal of Medical Biochemistry · doi:10.2478/v10011-010-0028-5 · Cited by 4
Kanakis, G., Kamp, K., Tsiveriotis, K., Feelders, R. A., Ζορμπαλά, Α., de Herder, W. W., & Kaltsas, G. (2012) · Clinical Endocrinology · doi:10.1111/cen.12046 · Cited by 5
Self-citationBorson‐Chazot, F. (2006) · Annales d Endocrinologie · doi:10.1016/s0003-4266(06)72587-2 · Cited by 4
“Ceci a conduit, tout naturellement, à rechercher l’intérêt d’une utilisation des analogues radio-marqués de la somatostatine, à fortes doses, dans un but thérapeutique, chez des patients porteurs de tumeurs endocrines évoluées en échec des traitements conventionnels [8, 10].”
BackgroundInfluentialAf, C., Egorov, A. V., Musaev, G. K., Fominykh, E. V., Sa, K., Vasil'ev, I. A., Parnova, V. A., & Anisimova, O. V. (2013) · PubMed · Cited by 8
Neuroendocrine Tumors in the Stomach, Duodenum, and Pancreas Accompanied by Novel MEN1 Gene Mutation
Yang, M. A., Lee, W. K., Shin, H. S., Park, S. H., Kim, B.-S., Kim, J. W., Cho, J. W., & Yun, S. H. (2017) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2017.69.3.181 · Cited by 4
“are diagnosed based on expression of these neuroendocrine markers.(1) Gastroenteropancreatic (GEP) NETs can present synchronously with various genetic diseases, such as multiple endo-”
BackgroundParaneoplastic syndromes related to neuroendorine tumours
Kaltsas, G., Dimitriadis, G. K., Androulakis, I. I., & Grossman, A. B. (2017) · MDText.com, Inc. eBooks · doi:10.82444/warw.33754267 · Cited by 4
Self-citationGastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Kızılgül, M., & Delibaşı, T. (2014) · Translational gastrointestinal cancer · Cited by 4
Cloning and expression of neuron-specific enolase in the corpus luteum of dairy goats
Meng, X., Li, F., Chen, S., Tang, C., Zhang, W., Wang, Z., & Zhao, S. (2012) · Gene · doi:10.1016/j.gene.2012.04.058 · Cited by 3
Janež, A. (2012) · Case Reports in Endocrinology · doi:10.1155/2012/168671 · Cited by 3
“angioinvasion [10, 11].”
Neuroendokrine Tumoren – Epidemiologie und Endokrinologie
Rinke, A., & Gress, T. M. (2010) · Viszeralmedizin · doi:10.1159/000322314 · Cited by 5
Antoniadou, F., Korkolis, D. P., Koufopoulos, N. I., Manatakis, D. K., & Sakellariou, S. (2018) · Molecular and Clinical Oncology · doi:10.3892/mco.2018.1734 · Cited by 3
“The majority of NETs are sporadic and only 10% are familial, arising in the context of autosomal dominant inherited syndromes (MEN1-2, VHL, NF) (17,18).”
A Rare Case of Simultaneous Pheochromocytoma Accompanied with an Ileocecal Neuroendocrine Tumor
Eltawil, K. M., Whalen, C., Leal, J. N., MacDonald, J., & Prowse, O. (2022) · Case Reports in Oncology · doi:10.1159/000520384 · Cited by 3
Fohlen, A., Beaudouin, R., Alvès, A., Bouhier‐Leporrier, K., Pasik, C., & Pelage, J. (2023) · Cancers · doi:10.3390/cancers15164021 · Cited by 3
“The most common anatomical sites of origin are the gastrointestinal tract, the pancreas and, more rarely, the lungs [3].”
BackgroundCosme, Á., Álvarez, M., Beguiristain, A., Cobo, A. M., Robledo, M., Aranzadi, M. J., Ojeda, E., Bujanda, L., & Goikoetxea, U. (2008) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(08)75811-4 · Cited by 3
Champaneria, M. C., Modlin, I. M., Latich, I., Bornschein, J., Drozdov, I. A., & Kidd, M. S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-337-0_25 · Cited by 3
Carcinome neuro-endocrine du tractus digestif : revue de la littérature
Jacob, J., Chargari, C., Hélissey, C., Ferrand, F., Ceccaldi, B., Moulec, S. L., Bauduceau, O., Fayolle, M., & Védrine, L. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2013.02.013 · Cited by 3
Tauchmanovà, L., Pensabene, M., Capuano, I., Spagnoletti, I., Zeppa, P., Vecchio, S. D., Mainenti, M., Rosa, G. D., Colao, A. A. L., & Contegiacomo, A. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347206 · Cited by 3
Wang, H. S., Oh, D. S., Ohning, G., & Pisegna, J. R. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.12.0009 · Cited by 3
“However, as an antiproliferative agent, its success has been modest, with reported tumoural response rates generally varying between 5% and 11% (Kaltsas et al 2004).”
BackgroundResultGlucagonoma with two pancreatic masses and pulmonary metastases as debut of MEN-1
Gutiérrez, V., Cobo, M., Olea, D., García, J., Ramírez, C. A. G., Bautista, D., & Alcalde, J. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0121-5 · Cited by 3
“The technique also enables the response to somatostatin analogues to be predicted and the progression monitored [1, 3, 6 ].”
BackgroundMethodParaganglioma: A cause of hypertension in a young patient
Rakonjac, N., & Markovic, S. (2012) · Vojnosanitetski pregled · doi:10.2298/vsp1208721r · Cited by 3
Mangueira, P. A., Fernandes, G. O., Primo, C. C., França, M. A. V., Maia, H. P., & Costa, J. H. G. (2006) · Revista Brasileira de Coloproctologia · doi:10.1590/s0101-98802006000200007 · Cited by 6
“Rev bras Coloproct, 2006;26(2):162-167.”
RETRACTED ARTICLE: Rare Orbitocranial Tumour in an Adult
Mehta, A., & Chandra, M. (2009) · Orbit · doi:10.3109/01676830902920652 · Cited by 3
RetractedThe Effect of Delay in Diagnosis in Patients with Neuroendocrine Tumors
Keizer, A. C., Korse, T., Meijer, W. G., & Tesselaar, M. E. T. (2016) · International Journal of Endocrine Oncology · doi:10.2217/ije.15.32 · Cited by 3
Rydzewska, G., Cichocki, A., Ćwikła, J., Kos‐Kudła, B., Krzyżanowska‐Świniarska, B., Nasierowska-Guttmejer, A., Szawłowski, A., & Tomaszewska, R. (2008) · PubMed · Cited by 3
Nonlinear optical microscopy for label-free detection of gastrointestinal neuroendocrine tumors
Li, L., Jiang, L., Chen, Z., Kang, D., Yang, Z., Liu, X., Jiang, W., Zhuo, S., Guan, G., Zhou, Y., et al. (2016) · Lasers in Medical Science · doi:10.1007/s10103-016-1964-1 · Cited by 3
Campana, D., & Tomassetti, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-29203-8_1 · Cited by 3
Clinicopathological Features of Gastroenteropancreatic Neuroendocrine Neoplasms
Şekerci, A., Türk, H. M., Demir, T., Şeker, M., Akçakaya, A., & Arıcı, D. S. (2020) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2020.08.863 · Cited by 3
A Case of a Rare Parathyroid Hormone (PTH)-Producing Neuroendocrine Tumor
Quinn, C. D., Chaudhary, F., Gould-Simon, A., Chen, B., Bhandal, H. S., & Chaudhary, U. B. (2022) · American Journal of Case Reports · doi:10.12659/ajcr.935783 · Cited by 3
“It is an inherited disorder in approximately 5% to 10% of all cases, but otherwise primary hyperparathyroidism tends to be acquired sporadically [1].”
BackgroundIgaz, P., Rácz, K., & Tulassay, Z. (2007) · Orvosi Hetilap · doi:10.1556/oh.2007.28231 · Cited by 3
“carcinoids, gastrinoma) are efficiently reduced by somatostatin analogue treatment [5, 20, 21].”
BackgroundWhen Should Everolimus Be Administered in the Natural History of Pancreatic Neuroendocrine Tumors?
Amoroso, V., Fazio, N., Mosca, A., Roca, E., Spada, F., Foroni, C., Agazzi, G. M., & Berruti, A. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.0103 · Cited by 3
Haugland, T. (2013) · NORA - Norwegian Open Research Archives · Cited by 3
Neuroendocrine Tumors: A Multidisciplinary Approach
Papotti, M. (2015) · Frontiers of hormone research · doi:10.1159/isbn.978-3-318-02773-0 · Cited by 2
Ovarian neuroendocrine tumor metastasis on DOTATATE PET/CT
Rojas, K. N., Chelikani, K. V., Villanueva-Meyer, J., & Bhargava, P. (2024) · Radiology Case Reports · doi:10.1016/j.radcr.2024.08.059 · Cited by 2
“Due to the variety of neuroendocrine cell types in our bodies, the clinical symptoms of NETs vary extensively and are heavily dependent on the site of tumor growth [ 2 ,3 ].”
BackgroundRanallo, N., Roncadori, A., Gentili, N., Balzi, W., Altini, M., Ghini, V., Maltoni, R., Andalò, A., Cavallucci, M., Sansovini, M., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13020515 · Cited by 2
“Neuroendocrine neoplasms (NETs) represent a rare and heterogeneous group of tumours that arise from neuroendocrine system cells involved in the release of peptides and amines with local activity [1].”
Novel radiohybrid PET-Tracers for SST2-targeted imaging of neuroendocrine tumors
Wendlinger, L., Parzinger, M., Litvinenko, A., Viertl, D., Spatz, P., Wurzer, A. J., Wester, H., & Schottelius, M. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07638-9 · Cited by 2
“Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms originating from the neuroendocrine system [1 ], representing only 0.49% of cancers [ 2 ].”
InfluentialGlucagon test in insulinoma: Is it useful?
Felício, J. S., Martins, C. L. L. P., Miléo, K. B., Semer, M., Kalinin, L., Nery, M., Machado, M. C. C., & Liberman, B. (2012) · PubMed · doi:10.3275/7879 · Cited by 3
Wongso, H. (2019) · Indonesian Journal of Cancer Chemoprevention · doi:10.14499/indonesianjcanchemoprev10iss2pp101-113 · Cited by 2
Myers, A., & Chitwood, H. (2020) · Clinical journal of oncology nursing · doi:10.1188/20.cjon.129-133 · Cited by 2
A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide
Yamaoka, K., Nagashima, S., Okada, N., Sawayama, N., Saito, S., Takahashi, M., Okada, K., Endo, K., Koizumi, M., Sasanuma, H., et al. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4118 · Cited by 3
Neuroendocrine tumors (NETs) – experience of a single Center
Şincu, M. C., Cocuz, I. G., Tinca, A. C., Niculescu, R., Sabău, A.-H., Chiorean, D. M., Morariu, S. H., & Cotoi, O. S. (2022) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.62.2.11 · Cited by 2
“This diffuse NE system also includes the endocrine cells that are located in the respiratory and digestive tracts [2, 3].”
BackgroundHaidar, M., Mahmasani, L. A., Chehade, L., Elias, C., Jebai, M. E., Temraz, S. N., Charafeddine, M., Darazi, M. H. A., & Shamseddine, A. I. (2023) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001683 · Cited by 2
Sood, A., Munir, M., Syed, O., Mehta, V., Kaur, R., Kumar, A. P., Sridhar, A., Sood, A., & Gupta, R. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2365823 · Cited by 2
“Some NETs are characterized by the presence of dense core granules, similar to those found in serotonergic neurons that store monoamines [2], while others are characterized by their ability to synthesize and secrete monoamines [3].”
INSM1 expression in neuroendocrine tumors in a tertiary care hospital
Chandrasekaran, K., Sundaram, S., & Balasubramanian, S. (2023) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_2329_22 · Cited by 2
Fulminante Duodenalblutung als Erstmanifestation eines neuroendokrinen Pankreaskopfkarzinoms
Schütte, K., Bornschein, J., Kuester, D., Wieners, G., & Malfertheiner, P. (2010) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-010-1043-5 · Cited by 2
An Adrenocorticotropic Hormone-secreting Malignant Pancreatic Neuroendocrine Tumor
Song, E. M., Lee, K. E., Jo, J. Y., Koo, H., Choi, M. Y., Seong, C., & Lee, S. N. (2011) · The Korean Journal of Internal Medicine · Cited by 2
Bolanowski, M., & Kos‐Kudła, B. (2005) · PubMed · Cited by 2
Tumor neuroendocrino: descripción de 2 casos de evolución atípica
Arrue, I., Arregui, M. A., Catón, B., & Soloeta, R. (2012) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2012.10.014 · Cited by 2
Giammarile, F., & Scheiber, C. (2012) · Médecine Nucléaire · doi:10.1016/j.mednuc.2012.06.001 · Cited by 2
Neuroendocrine tumors and gut hormones
Barakat, M. T., & Meeran, K. M. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.med.0000151394.58657.f6 · Cited by 2
Guo, T., Ng, K. K., Chiang, H. W., Fei, M., Lin, Y., & Qian, J. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0430-6 · Cited by 2
“As poorly differentiated NECs rarely occur in sites outside the tracheobronchial tree [2], to the best of our knowledge, here we first describe a case of poorly differentiated gastrointestinal neuroendocrine carcinoma,presentingwith extensivehepatic andbonymetastases as the primary manifestation.”
BackgroundInfluentialNeuroendocrine TumorWith an Atypical Clinical Course: A Description of 2 Cases
Arrue, I., Arregui, M. A., Catón, B., & Soloeta, R. (2014) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2012.10.020 · Cited by 2
“Some tumors may follow an aggressive course, although most are slow-growing and indolent.(1) The main tumors to be included in the differential diagnosis are basal cell carcinoma and cutaneous lymphoma.”
BackgroundInfluentialVerner-Morrison syndrome: a case study
Halászlaki, C., Horváth, H. C., Kiss, L. S., Takács, I., Speer, G., Nagy, Z., Winternitz, T., Dabasi, G., Zalatnai, A., Patócs, A., et al. (2010) · Orvosi Hetilap · doi:10.1556/oh.2010.28884 · Cited by 2
Multiple Endocrine Neoplasia: Paediatric Perspective
Rodríguez-Sánchez, A. B., de Salazar, C. L.-M. O., & Rodriguez-Arnao, M. D. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.s1.1237 · Cited by 2
Pusuwan, P., Tocharoenchai, C., Sriussadaporn, S., Muangsomboon, K., Poramatikul, N., & Tiparoj, R. (2010) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Lanreotide Autogel in the Treatment of Persistent Diarrhea following a Total Colectomy
Schoeters, P., & Pooter, K. D. (2015) · Case Reports in Gastrointestinal Medicine · doi:10.1155/2015/686120 · Cited by 2
Role of nuclear medicine techniques in the management of disease in infants
Santra, A., Sharma, P., Malhotra, A., & Kumar, R. (2008) · Journal of Neonatology · doi:10.1177/0973217920080308 · Cited by 2
Systemic therapies for advanced gastroenteropancreatic neuroendocrine tumors
Patel, D., Chan, D. L. H., Cehic, G., Pavlakis, N., & Price, T. J. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1199952 · Cited by 2
“On the other hand, functional tumors may present with symptoms related to the active hormone being secreted, such as serotonin, gastrin, insulin, prostaglandins, or histamine [11-13].”
BackgroundSporadic Gastroenteropancreatic Neuroendocrine Tumors
Appetecchia, M., Lauretta, R., Rota, F., & Carlini, M. (2017) · Updates in surgery/Updates in surgery series · doi:10.1007/978-88-470-3955-1_4 · Cited by 2
Tumour Detection in Syndromic NET: Carcinoid Syndrome
Dimitriadis, G. K., & Kaltsas, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-59024-0_10 · Cited by 2
Self-citationTumor Neuroendokrin: Kasus Serial di RSUD Dr. Soetomo
Mahayasa, M., & Wibowo, P. S. (2018) · JBN (Jurnal Bedah Nasional) · doi:10.24843/jbn.2018.v02.i01.p05 · Cited by 4
“cukup untuk dapat memperbaiki kualitas hidup.(2,5,18) Pada pasien dengan well differentiated neuroendokrin tumor atau tipe carcinoids, yang menunjukkan indeks proliferasi rendah, maka bioterapi (analog somatostatin dan interferon-α) adalah pengobatan pilihan, karena aktivitas biologis yang intensif dari tumor ini berk…”
Sanabria, C., Pérez‐Ferre, N., Lecumberri, E., & de Miguel, P. (2007) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(07)71515-2 · Cited by 2
Neuroendocrine neoplasm: Current understanding
Lila, A. R., & Memon, S. (2023) · Journal of Postgraduate Medicine · doi:10.4103/jpgm.jpgm_51_23 · Cited by 2
“[2] The epithelial NENs of the digestive or respiratory tracts were traditionally described as carcinoid tumors.”
Alemi, H., Khavandgar, N., Oskouie, I. M., Mardani-Fard, H. A., Rostami, T., Aletaha, A., Peykari, N., Alikhani, M., Sajjadi‐Jazi, S. M., Kasaeian, A., et al. (2024) · Medicine · doi:10.1097/md.0000000000038511 · Cited by 2
Should Malnutrition Screening be Routine for Patients with GEP-NET?
Weickert, M. O. (2016) · International Journal of Endocrine Oncology · doi:10.2217/ije-2016-0013 · Cited by 2
Neuroendocrine tumor of parapharyngeal space
Adham, M., & Widayanti, N. (2013) · Oto Rhino Laryngologica Indonesiana · doi:10.32637/orli.v43i1.15 · Cited by 1
“On follow up the patient doesn’t have any complaint, no hoarseness nor difficulty in swallowing.(14) Successful treatment of disseminated neuroendocine tumors requires a multimodal approach; radical tumor surgery may”
BackgroundPikunov, M. Y., Савельева, Т. В., Белая, Ж. Е., Алексеевна, Б. С., & Дегтярев, М. В. (2022) · Хирургия Восточная Европа · doi:10.34883/pi.2022.11.2.004 · Cited by 1
Alpha Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
Beydağı, G., Selçuk, N. A., & Kabasakal, L. (2023) · Nuclear Medicine Seminars · doi:10.4274/nts.galenos.2023.0015 · Cited by 1
Huang, Y., Su, S., & Huang, T. (2025) · Journal of Medical Sciences · doi:10.4103/jmedsci.jmedsci_48_25 · Cited by 1
Liver Metastases from Neuroendocrine Tumors
Kennedy, A. S. (2014) · Future Oncology · doi:10.2217/fon.14.231 · Cited by 1
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014
Tsvetkova, E. V., Sud, S., Aucoin, N., Biagi, J. J., Burkes, R. L., Samson, B., Brule, S. Y., Cripps, C., Colwell, B., Falkson, C. B., et al. (2015) · Current Oncology · doi:10.3747/co.22.2603 · Cited by 1
Pancreatic Neuroendocrine Tumors
Tsolakis, A. V., & Kanakis, G. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_50-2 · Cited by 1
A Rare Gastric Carcinoma- Neuroendocrine Tumors
Svorcan, P., Djordjevic, J., & Maksimovic, B. (2011) · InTech eBooks · doi:10.5772/17554 · Cited by 1
“They can be subclassified into 3 distinct groups: those associated with chronic atrophic gastritis/pernicious anemia (type 1; 70%-80%), those associated with Zollinger-Ellison syndrome (ZES) with multiple endocrine neoplasia type I (MEN I) (type 2; 5%), and sporadic NETs of the stomach (type 3; 15%-20%) (13-15).”
BackgroundTransarterial chemoembolization in the management of primary and secondary liver tumors
Ruutiainen, A. T., & Soulen, M. C. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511575433.006 · Cited by 1
Октреотид в лечении нейроэндокринных опухолей: достигнут ли успех?
Morgunov, L. Y. (2015) · Research and Practical Medicine Journal · doi:10.17709/2409-2231-2015-2-2-63-72 · Cited by 1
Tõke, J., Czirják, G., Tóth, M., Rácz, K., & Patócs, A. (2014) · Orvosi Hetilap · doi:10.1556/oh.2014.30035 · Cited by 2
Radionuclide Therapy of Neuroendocrine Tumors
Mallia, A., Maccauro, M., Seregni, E. C., Bampo, C., Chiesa, C., & Bombardieri, E. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4021-5_4 · Cited by 1
Paraganglioma abdominal. Ecoendoscopia como nueva herramienta diagnóstica
Espín, R. G., Martín, A., Delgado, P. E., García, E. F., González, I. O., Higueras, A. L., Alcazar, E., & Herranz, M. (2014) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2014.07.005 · Cited by 1
Gastroenteropancreatic Neuroendocrine Tumours – An Institutional Experience
Joseph, T., & Shanthala, P. R. (2015) · International Journal of Biomedical Research · doi:10.7439/ijbr.v6i2.1497 · Cited by 1
“Type 3 gastric carcinoids are large, solitary, not associated with hypergastrinaemia and commonly metastasize[14].”
BackgroundResultMartin, A. I., & Horgan, N. (2012) · Eye · doi:10.1038/eye.2012.198 · Cited by 1
Neuroendocrine tumours: a hope and a prayer
Grossman, A. B. (2009) · Gut · doi:10.1136/gut.2008.164640 · Cited by 1
Self-citationMarazuela, M., & Bernabéu, I. (2007) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(07)71518-8 · Cited by 1
Preclinical Studies of SPECT and PET Tracers for NET
Brom, M., Boerman, O. C., Gotthardt, M., & Oyen, W. J. G. (2013) · PET Clinics · doi:10.1016/j.cpet.2013.08.012 · Cited by 1
“These tumors are derived from endocrine glands such as the adrenal medulla, pituitary, parathyroid, endocrine islets of the pancreas and thyroid as well as dispersed endocrine cells between the exocrine tissue of the respiratory and digestive system.(2) Most NETs are slow-growing tumors (well-differentiated NETs), whe…”
BackgroundLarge retroperitoneal paraganglioma concurrent with periampullary adenocarcinoma.
Hakimian, S. M., Naimi, A., Emami, S. M., Rozatii, G., & Goharian, V. (2013) · PubMed Central · Cited by 1
Gastric Carcinoid Tumors: The Problems Encountered in Diagnosis and Treatment
Yüksel, O. (2013) · International Journal of Hematology and Oncology · doi:10.4999/uhod.10034 · Cited by 1
“However, it is difficult to change their same poor outcome.(3,15-17) The 5-year survival of type I and IV gastric carcinoid tumors were 69.”
BackgroundLi, Z. (2016) · PubMed Central · doi:10.3785/j.issn.1008-9292.2016.01.03 · Cited by 1
Metadata
- Authors
- Kaltsas, G. A., Besser, G. M., & Grossman, A. B.
- Affiliations
- St Bartholomew's Hospital (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-06-01
- Volume
- 25
- Issue
- 3
- Pages
- 458-511
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2031301095
- Semantic Scholar
- b09a37699a89446c4662f1bc87eb975bf31118b7
- Cited by
- 674
- References
- 670
- Citations by year
- 2026: 4 · 2025: 19 · 2024: 17 · 2023: 26 · 2022: 17 · 2021: 23 · 2020: 23 · 2019: 24 · 2018: 31 · 2017: 27 · 2016: 34 · 2015: 46 · 2014: 30 · 2013: 37 · 2012: 49
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- neuroendocrine tumors, diagnosis, tumor markers, endocrine syndromes, somatostatin analogues, MIBG scintigraphy, endoscopic ultrasound, interferon-alpha, chemotherapy, radionuclide therapy, multimodal therapy, quality of life
- MeSH terms
- Adrenal Gland Neoplasms, Animals, Antineoplastic Combined Chemotherapy Protocols, Gastrointestinal Neoplasms, Humans, Pancreatic Neoplasms, Parathyroid Neoplasms, Pituitary Neoplasms, Prognosis, Quality of Life, Sensitivity and Specificity, Somatostatin, Thyroid Neoplasms, Tomography, X-Ray Computed, Biomarkers, Tumor, Interferon-alpha, Carcinoma, Neuroendocrine, Neuroendocrine Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.